68 related articles for article (PubMed ID: 2525805)
1. Effect of dopamine and dopamine-antagonist infusion on blood platelet count, size and release reaction in hypertensive and normotensive subjects.
Lande K; Os I; Kjeldsen SE; Westheim A; Hjermann I; Eide I; Gjesdal K
Scand J Clin Lab Invest; 1989 Jun; 49(4):307-15. PubMed ID: 2525805
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet size and release reaction in essential hypertension.
Lande K; Os I; Kjeldsen SE; Westheim A; Hjermann I; Eide I; Gjesdal K
J Hypertens; 1987 Aug; 5(4):401-6. PubMed ID: 2959720
[TBL] [Abstract][Full Text] [Related]
3. Effects of adrenaline infusion on serum thromboxane B2 and plasma beta-thromboglobulin levels in hypertensive and normotensive subjects.
Douma S; Zamboulis C; Karagiannis A; Sinakos Z
Nouv Rev Fr Hematol (1978); 1992; 34(1):73-8. PubMed ID: 1387933
[TBL] [Abstract][Full Text] [Related]
4. Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension.
Lande K; Kjeldsen SE; Os I; Westheim A; Hjermann I; Eide I; Gjesdal K
J Hypertens; 1988 Mar; 6(3):219-25. PubMed ID: 2966193
[TBL] [Abstract][Full Text] [Related]
5. Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension.
Os I; Kjeldsen SE; Westheim A; Lande K; Norman N; Hjermann I; Eide I
Scand J Clin Lab Invest; 1987 Jun; 47(4):371-7. PubMed ID: 3602915
[TBL] [Abstract][Full Text] [Related]
6. Does increased platelet release normalize during anti-hypertensive treatment?
Lande K; Kjeldsen SE; Eide I; Leren P; Gjesdal K
Thromb Haemost; 1987 Oct; 58(3):834-8. PubMed ID: 2963402
[TBL] [Abstract][Full Text] [Related]
7. Effects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects.
Contreras F; Fouillioux C; Lares M; Bolívar H; Hernández RH; Velasco M; Cano R; Chacin M; Bermúdez V
Am J Ther; 2010; 17(3):320-4. PubMed ID: 20216207
[TBL] [Abstract][Full Text] [Related]
8. Platelet volume, platelet release reaction and platelet response to infused adrenaline are increased in essential hypertension.
Lande K; Os I; Kjeldsen SE; Westheim A; Aakesson I; Hjermann I; Eide I; Gjesdal K
Acta Med Scand Suppl; 1986; 714():129-32. PubMed ID: 2953174
[TBL] [Abstract][Full Text] [Related]
9. Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women.
Mundal HH; Nordby G; Lande K; Gjesdal K; Kjeldsen SE; Os I
Scand J Clin Lab Invest; 1993 Oct; 53(6):585-91. PubMed ID: 8266004
[TBL] [Abstract][Full Text] [Related]
10. [In vivo platelet activation in mild arterial hypertension].
Guicheney P; Baudouin-Legros M; Meyer P
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
[TBL] [Abstract][Full Text] [Related]
11. Decreased central dopaminergic activity in essential hypertension.
Os I; Kjeldsen SE; Westheim A; Aakesson I; Norman N; Enger E; Hjermann I; Eide I
J Hypertens; 1987 Apr; 5(2):191-7. PubMed ID: 3611768
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of metoclopramide for endocrine versus renal effects of dopamine in normal humans.
Blumberg AL; Dubb JW; Allison NL; Aldins Z; Ramey K; Stote RM
J Cardiovasc Pharmacol; 1988 Feb; 11(2):181-6. PubMed ID: 2452312
[TBL] [Abstract][Full Text] [Related]
13. Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension.
Kjeldsen SE; Gjesdal K; Leren P; Eide IK
Thromb Haemost; 1988 Oct; 60(2):251-4. PubMed ID: 3217920
[TBL] [Abstract][Full Text] [Related]
14. Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
Zacharieva S; Stoeva I; Matrozov P; Andonova K
Exp Clin Endocrinol; 1990 Aug; 95(3):331-8. PubMed ID: 2245821
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of low dose nicotine gum on platelet function in non-smoking hypertensive and normotensive men.
Mundal HH; Hjemdahl P; Gjesdal K
Eur J Clin Pharmacol; 1995; 47(5):411-6. PubMed ID: 7720762
[TBL] [Abstract][Full Text] [Related]
16. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma noradrenaline during severe sodium restriction does not stimulate platelet release in essential hypertension.
Kjeldsen SE; Lande K; Gjesdal K; Jackson MB; Westheim A; Frederichsen P; Leren P; Eide I
Thromb Haemost; 1986 Oct; 56(2):120-3. PubMed ID: 2949387
[TBL] [Abstract][Full Text] [Related]
18. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F
J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397
[TBL] [Abstract][Full Text] [Related]
19. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H
Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
